Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
05/15/2013 | CN101773511B Compound topical combination drug for treatment of acne and preparation method thereof |
05/15/2013 | CN101744841B Bifidobacterium for treating inflammatory disease |
05/15/2013 | CN101641103B Use of chitosans in preparing medicine for the treatment of nail inflammatory diseases |
05/15/2013 | CN101516386B Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
05/15/2013 | CA2795586A1 Methods and compositions for treatment, modification and management of bone cancer pain |
05/14/2013 | US8440696 Method of using diketopiperazines and composition containing them |
05/14/2013 | US8440654 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor |
05/14/2013 | US8440644 Compounds as receptor modulators with therapeutic utility |
05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
05/14/2013 | CA2516624C 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
05/14/2013 | CA2497572C Akt inhibitors, pharmaceutical compositions, and uses thereof |
05/14/2013 | CA2465753C Orodispersible tablet having high homogeneity and the preparation method thereof |
05/14/2013 | CA2460352C Composition and transdermal drug delivery device |
05/14/2013 | CA2455915C Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
05/14/2013 | CA2434303C Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
05/14/2013 | CA2362606C Therapeutic antimicrobial compositions |
05/10/2013 | WO2013067084A1 Silylated azulenyl nitrone spin traps as chromotropic superoxide detectors |
05/10/2013 | WO2013066179A1 Liposomal corticosteroids for treatment of inflammatory disorders in humans |
05/10/2013 | WO2013065825A1 Cationic lipid |
05/10/2013 | WO2013064884A1 Quaternized amines as sodium channel blockers |
05/10/2013 | WO2013064508A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof |
05/10/2013 | WO2013064468A1 Indole inhibitors of crac |
05/10/2013 | WO2013064445A1 Imidazopyridazine compounds |
05/10/2013 | WO2013064153A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids) |
05/10/2013 | WO2013064031A1 N-benzylaniline derivative and uses thereof |
05/10/2013 | WO2012170504A3 Treatment of extracellular matrix to reduce inflammation |
05/10/2013 | WO2012167133A3 Inhibitors of anandamide transport and their therapeutic uses |
05/10/2013 | WO2012160448A3 Anti-kir antibodies for the treatment of inflammatory disorders |
05/10/2013 | CA2854430A1 Liposomal corticosteroids for treatment of inflammatory disorders in humans |
05/10/2013 | CA2854134A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof |
05/10/2013 | CA2854066A1 Cationic lipid |
05/10/2013 | CA2849194A1 Imidazopyridazine compounds |
05/09/2013 | US20130116309 Oligomeric compounds for the modulation of hif-1a expression |
05/09/2013 | US20130116279 Bicyclic heteroaryl inhibitors of pde4 |
05/09/2013 | US20130116268 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
05/09/2013 | US20130116219 Antimicrobial carboline compounds |
05/09/2013 | US20130115270 Anti-interleukin-1 (IL-1) antibody used as a targeting agent to treat arthritis and other diseases |
05/09/2013 | US20130115269 Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseases |
05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
05/09/2013 | US20130115191 T cell receptor fusions and conjugates and methods of use thereof |
05/08/2013 | EP2589592A1 Novel nicotinamide derivatives or salts thereof |
05/08/2013 | EP2588498A1 Llt-1 antibodies with new functional properties |
05/08/2013 | EP2588480A2 3,4-DIHYDROPYRROLO[1,2-A]PYRAZINE-2,8(1H)-DICARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF& xA; |
05/08/2013 | EP2588475A1 Apoptosis signal-regulating kinase inhibitors |
05/08/2013 | EP2588473A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors |
05/08/2013 | EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
05/08/2013 | EP2588469A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
05/08/2013 | EP2588468A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
05/08/2013 | EP2588459A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
05/08/2013 | EP2588104A1 Isoindolone m1 receptor positive allosteric modulators |
05/08/2013 | CN202920665U Musk bone-strengthening paste |
05/08/2013 | CN202920662U Ointment plaster for relaxing muscles and tendons and stimulating blood circulation |
05/08/2013 | CN202920448U Neck hot compress bag |
05/08/2013 | CN103097392A Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
05/08/2013 | CN103097382A 2-(arylamino)-3H-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as MPGES-1 inhibitors |
05/08/2013 | CN103097381A 1, 8-naphthyridines as kinase inhibitors |
05/08/2013 | CN103097375A Cyclohexyl-azetidinyl antagonists of CCR2 |
05/08/2013 | CN103097365A 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (S1P) receptors |
05/08/2013 | CN103097359A New compounds |
05/08/2013 | CN103097358A Pharmaceutical composition |
05/08/2013 | CN103096916A Formulations for bovine granulocyte colony stimulating factor and variants thereof |
05/08/2013 | CN103096914A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
05/08/2013 | CN103096913A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
05/08/2013 | CN103096912A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
05/08/2013 | CN103096911A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
05/08/2013 | CN103096910A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases |
05/08/2013 | CN103096899A Inhibitor of hmgb protein-mediated immune response activation, and screening method |
05/08/2013 | CN103091445A Quality detection method of Eleutherine plicata Herb and extract thereof |
05/08/2013 | CN103088083A Method for preparing anti-inflammation and anti-tumor activity sesquiterpene lactone compounds |
05/08/2013 | CN103087262A Sodium alginate-polystyrene copolymer synthesis by using ultrasound method |
05/08/2013 | CN103087254A Preparation method and applications of amphiphilic co-network resin |
05/08/2013 | CN103087196A Preparation method of muramyl dipeptide-anti-CD20 immune conjugate and application thereof |
05/08/2013 | CN103087192A Anti-KDR antibodies and methods of use |
05/08/2013 | CN103087190A Anti-gm-csf antibodies and uses therefor |
05/08/2013 | CN103087153A New neovessel inhibition small peptides and applications thereof |
05/08/2013 | CN103087151A Novel polypeptide used for treating tissue inflammation |
05/08/2013 | CN103087137A Glucocorticoid with sulfoalkyl group at position 21 |
05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
05/08/2013 | CN103087053A Preparation of oxadiazole compound and application thereof to anti-inflammatory treatment |
05/08/2013 | CN103087026A Crystal form D of 7-hydroxyl isoflavone, preparation method of crystal form D and medicine composition and use of crystal form D |
05/08/2013 | CN103086987A (1,2,3-triazolyl) sulfonyl derivative |
05/08/2013 | CN103086981A New compounds |
05/08/2013 | CN103086971A Nitrogenous heterocyclic derivative, preparation method thereof and application thereof in preparation of histone deacetylase I inhibitor |
05/08/2013 | CN103086943A Indoles derivative functioning as CRTH2 receptor antagonist |
05/08/2013 | CN103086923A Hydrazine cathepsin K inhibitor and application thereof in treating osteoporosis |
05/08/2013 | CN103086908A N-benzylaniline derivatives and application thereof |
05/08/2013 | CN103086863A Alkannin dimer compounds and uses of the same in drug preparation |
05/08/2013 | CN103083740A Method for treating joint disease and skin disease by utilizing Chinese medicine acupuncture and cupping technology |
05/08/2013 | CN103083677A Permeation accelerator and application thereof to permeation acceleration |
05/08/2013 | CN103083675A Traditional Chinese medicine vertebral cataplasm substrate and preparation method thereof |
05/08/2013 | CN103083672A DPP-IV inhibitor combined with further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
05/08/2013 | CN103083670A Application of inhibiting agent of cathepsin K |
05/08/2013 | CN103083669A Method for treatment of inflammatory disease and disorder |
05/08/2013 | CN103083642A Aloe preparation for skin enhancement |
05/08/2013 | CN103083639A Medicament for treating postpartum pain of body |
05/08/2013 | CN103083637A Pharmaceutical composition for treating rheumatism |
05/08/2013 | CN103083602A Externally used pharmaceutical composition for treating lumbar disease |
05/08/2013 | CN103083598A Chinese patent medicine for treating chronic osteomyelitis |